Results 111 to 120 of about 79,543 (254)

New approaches in the haemostatic management of postpartum haemorrhage. [PDF]

BMJ Med
Cox C, Neave L, Hunt BJ.
europepmc   +1 more source

Clinical Outcomes After Percutaneous Coronary Intervention in Patients With Cirrhosis: A Multicentre National Study

Alimentary Pharmacology &Therapeutics, EarlyView.
Summary of a multicentre TriNetX study evaluating outcomes after percutaneous coronary intervention (PCI) in patients with cirrhosis. Cirrhosis was associated with higher 1‐year gastrointestinal bleeding and mortality, especially with decompensated disease.
Dhir Gala, Sameer Rao, Manas Gunani, Kajol Shah, Anand V. Kulkarni, Karn Wijarnpreecha, Daniel Q. Huang, Pojsakorn Danpanichkul, Ahmed Al‐Khazraji, Kaveh Hajifathalian, Vivek Lingiah, Paul Gaglio, Nikki Duong, Christine Gerula   +13 more
wiley   +1 more source

Microbial proteases and endothelial barrier disruption in sepsis: A neglected nexus. [PDF]

Virulence
Rao SS, Shenoy M S, Gutti RK, Prabhu V, Joshi M, Nayak UY, Bharath Prasad AS.   +6 more
europepmc   +1 more source

Adherence to Stillbirth Guidelines and Women's Psychological Well‐Being: The CLASS (CiaoLApo Stillbirth Support) Cross‐Sectional Study

Birth, EarlyView.
CLASS checklist adherence was evaluated in a web‐based survey of 261 women who experienced stillbirth in Italy. Greater adherence to evidence‐based stillbirth care guidelines was associated with higher satisfaction and respectful care, as well as lower levels of perinatal grief and PTSD symptoms.
Claudia Ravaldi, Francesca Roper, Laura Mosconi, Alfredo Vannacci   +3 more
wiley   +1 more source

Acute Intraoperative Disseminated Intravascular Coagulation During Suppurative Keloid Excision: A Case Report. [PDF]

Am J Case Rep
Nguyen BL, Pham MQ, Nguyen TH, Nguyen NTC, Ngo KX, Nguyen MT, Pham AQ, Vo TT, Hoang HV.   +8 more
europepmc   +1 more source

Janus kinase inhibitors after ruxolitinib failure in myelofibrosis: A systematic review and pooled analysis of phase 3 efficacy and integrated safety across clinical trials and real‐world evidence

British Journal of Haematology, EarlyView.
Summary Ruxolitinib remains first‐line standard of care for symptomatic myelofibrosis, but resistance/intolerance develops in most patients. Three Janus kinase inhibitors (JAKis) have entered the post‐ruxolitinib space via distinct pivotal trials. We systematically searched prospective trials evaluating JAKi in refractory adults with myelofibrosis ...
Andrea Duminuco, Patrick Harrington, Elena Torre, Hillary Catellani, Novella Pugliese, Matteo Pacilli, Annalisa Santisi, Arianna Sbriglione, Giuseppe A. Palumbo   +8 more
wiley   +1 more source

Early Prediction of Sepsis-Related Coagulopathy: A Comparative Evaluation of Clinical Scoring Systems in the Emergency Department. [PDF]

J Clin Med
Petrucci M, Gemma S, Iozzia I, Della Polla DA, Bonadia N, Tullo G, Fanelli PMC, Gasbarrini A, Franceschi F, Covino M.   +9 more
europepmc   +1 more source

Lactate‐Primed NETosis Modulates Hepatic Regeneration During Acute Liver Failure via the TLR9/KLF15/AJUBA Axis

Cell Proliferation, EarlyView.
This study elucidates a novel Kupffer cell‐neutrophil‐hepatocyte axis that drives metabolic‐immune crosstalk during acute liver failure. Specifically, lactate‐primed NETs release links metabolic reprogramming to NETosis‐induced regenerative failure in hepatocytes via the TLR9/KLF15/AJUBA axis.
Jin Guo, Xiaoya Zhang, Danmei Zhang, Chunxia Shi, Luwen Wang, Zuojiong Gong   +5 more
wiley   +1 more source

Contained Juxtarenal Aortic Perforation in the Setting of Severe Warfarin-Associated Coagulopathy. [PDF]

JACC Case Rep
Shami B, Saif R, Yadana H, Mousselli I, Tahhan IS, Manoharan P.   +5 more
europepmc   +1 more source

Early tocilizumab and outcomes in acute necrotizing encephalopathy

Developmental Medicine &Child Neurology, EarlyView.
Early tocilizumab and outcome in acute necrotising encephalopathy. Aim To evaluate the timing and safety of tocilizumab in acute necrotizing encephalopathy (ANE). Method This was a multicentre retrospective study evaluating outcomes (modified Rankin Scale [mRS]) in children with ANE treated with tocilizumab. A logistic regression model determined a cut‐
Velda X Han, Prithuja Poudyal, Vanessa Lee, Arushi Gahlot Saini, Shekeeb S Mohammad, Sekhar C Pillai, Gouri Rao Passi, Naveen Sankhyan, Ahmad Rithauddin Mohamed, Lokesh Lingappa, Hiroshi Sakuma, Russell C Dale, Ming Lim, Terrence Thomas, for The International ANE Study Group   +14 more
wiley   +1 more source